Work

Extent of Drug Patents With Terminal Disclaimers and Obviousness-Type Double Patenting Rejections

Year: 2024
Type: article
Abstract: This study evaluates the frequency of terminal disclaimers filed by drug patent holders to obviate obviousness-type double patenting rejections associated with drug patent thickets.
Source: JAMA
Language: English
Open Access status: green
OpenAlex ID: W4401511427
FWCI: 1.337
Cites: 2
Cited by: 3
Related to: 10